Home> Products> iv fluids and supportive medicines

{ "products": [ { "_id": "6a994b74160c6c01069cb90b", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rosuvastatin and Fenofibrate 5 Tablet", "description": "Rosufree F 5\nRosuvastatin + Fenofibrate Tablets\n\nRosufree F 5 is a combination lipid-lowering medicine containing Rosuvastatin and Fenofibrate. It may be prescribed for selected patients with mixed dyslipidemia, where management of LDL cholesterol and triglycerides is required.\n\nMechanism : \n\nRosuvastatin Pathway\nHMG-CoA reductase blocked\n→ liver cholesterol production decreases\n→ LDL receptors increase\n→ more LDL is removed from blood\n\nFenofibrate Pathway\n\nPPAR-α activated\n→ triglyceride metabolism increases\n→ triglyceride-rich particles decrease\n→ lipid profile can improve\n\nWhy Rosufree F May Be Important\n\nIn appropriately selected patients, controlling mixed dyslipidemia can form part of a broader strategy to reduce atherosclerotic cardiovascular risk.\n\nThe combination may be considered when lifestyle measures and individual lipid-lowering treatment do not adequately address the patient's lipid pattern, particularly when triglycerides remain an important concern.\n\nTreatment should still be accompanied by appropriate:\n\nDiet modification\nRegular physical activity\nWeight management where appropriate\nDiabetes control where relevant\nSmoking cessation\nManagement of other cardiovascular risk factors\n\nSide Effects\n\nBecause Rosufree F contains two lipid-modifying medicines, adverse effects from both components need consideration.\n\nPossible Effects\nHeadache\nNausea\nAbdominal discomfort\nConstipation\nMuscle aches\nWeakness\nChanges in liver enzymes\n\nFenofibrate may also be associated with gastrointestinal symptoms and gallstone-related problems in susceptible patients.\n\nStorage & Handling\n\nFor appropriate product care:\n\nKeep Rosufree F 5 in its original blister and carton.\nFollow the storage temperature stated on the marketed product pack.\nProtect tablets from excessive heat and moisture.\nKeep the blister dry and undamaged.\nHandle tablets with clean, dry hands.\nDo not use medicine after the printed expiry date.\nAvoid using tablets from damaged packaging if product integrity is uncertain.\nKeep out of reach and sight of children.\nDo not transfer tablets into an unidentified container for prolonged storage.\n\n\nFrequently Asked Questions\n\n1. What is Rosufree F 5 used for?\nIt may be prescribed for selected patients with mixed lipid abnormalities where management of both cholesterol and triglycerides is clinically required.\n\n2. Why are Rosuvastatin and Fenofibrate combined?\nRosuvastatin primarily reduces LDL cholesterol, while Fenofibrate has a significant triglyceride-lowering effect.\n\n3. How does Fenofibrate work?\nFenofibrate activates PPAR-alpha, influencing lipid metabolism and increasing the breakdown of triglyceride-rich particles.\n\n4. Why is muscle pain important with Rosufree F?\nBoth statins and fibrates can cause muscle-related adverse effects. Persistent or unexplained muscle symptoms should be medically assessed.\n\n5. Does Rosufree F require kidney monitoring?\nKidney function can be particularly important for determining the safety and suitability of Fenofibrate therapy.\n\n6. Can Rosufree F affect the liver?\nYes. Both components can influence liver-related laboratory parameters, so liver assessment may be appropriate.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 486, "imageuri": "https://productimages.withfloats.com/actual/6a994b77856da455a43923b5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a994b77856da455a43923b5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-03T10:27:00.001Z", "updatedon": "2026-09-03T10:27:00.001Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN/products/rosuvastatin-and-fenofibrate-5-tablet/486", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rosufree F 5", "category": "cardiac", "tags": [ "Buy Rosufree-F 5 Tablet Online", "Rosuvastatin Fenofibrate Tablets", "Statin Fibrate Combination", "Rosufree F 5 Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a9946127b21caf23b4c3d20", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Telmisartan and Metoprolol Succinate 25mg", "description": "Telmaheal Beta 25 – Telmisartan & Metoprolol Succinate Tablets\n\nBlood Pressure & Cardiovascular Management\n\nTelmaheal Beta 25 is a combination cardiovascular medicine containing Telmisartan and Metoprolol Succinate. The two ingredients work differently: Telmisartan helps relax blood vessels, while Metoprolol Succinate reduces excessive stimulation of the heart. Together, they may provide better blood-pressure control in selected patients when combination therapy is clinically appropriate.\n\nWhy Is This Combination Important?\n\nHigh blood pressure often has more than one contributing mechanism. For some patients, controlling vascular resistance alone may not provide the desired response.\n\nTelmaheal Beta combines an ARB with a beta blocker, allowing treatment to act on both blood vessels and cardiac activity.\n\nPossible Side Effects\n\nSome patients may experience:\n\nDizziness\nTiredness\nHeadache\nSlow heartbeat\nLow blood pressure\nWeakness\nCold hands or feet\nNausea or stomach discomfort\nImportant Symptoms\n\nMedical attention may be required for:\n\nVery slow heart rate\nFainting\nSevere dizziness\nSignificant breathing difficulty\nNew or worsening heart-failure symptoms\nMarked fall in blood pressure\nSymptoms associated with high potassium levels\nSerious allergic reactions\n\nPregnancy Safety\n\nTelmisartan acts on the renin-angiotensin system and can cause serious fetal harm.\n\nTherefore, Telmisartan-containing medicines should not be used during pregnancy. A patient who becomes pregnant while receiving treatment should contact the treating healthcare professional promptly.\n\nImportant Medicine Interactions\n\nExtra attention may be required with:\n\nOther blood-pressure-lowering medicines\nMedicines that reduce heart rate\nCertain calcium-channel blockers\nDigoxin\nPotassium supplements\nPotassium-containing salt substitutes\nCertain diuretics\nNSAID painkillers\nLithium\n\nSafety Information for Patients\n\nTelmaheal Beta 25 should be used under medical supervision. Patients should not independently change the dose because of a single high or low blood-pressure reading.\n\nSpecial attention is needed if there is persistent dizziness, fainting, unusually slow pulse, breathing difficulty, significant weakness, swelling, or worsening cardiovascular symptoms.\n\nThe medicine should be taken according to the prescribed schedule, and regular follow-up remains important even when blood pressure appears controlled.\n\nFrequently Asked Questions\n\n1. What is Telmaheal Beta 25 used for?\nIt may be prescribed for hypertension and other appropriate cardiovascular situations where both Telmisartan and Metoprolol are clinically required.\n\n2. How does Telmaheal Beta 25 control blood pressure?\nTelmisartan relaxes blood vessels by blocking angiotensin II activity, while Metoprolol reduces excessive beta-1 stimulation of the heart.\n\n3. Can Telmaheal Beta 25 reduce heart rate?\nYes. Metoprolol can slow the heart rate as part of its therapeutic action.\n\n4. Why should potassium be monitored?\nTelmisartan can increase potassium levels, particularly in patients with kidney impairment or those taking other potassium-raising medicines.\n\n5. Can this medicine cause dizziness?\nYes. Dizziness may occur if blood pressure falls, particularly when starting or adjusting treatment.\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 483, "imageuri": "https://productimages.withfloats.com/actual/6a994614d071dc10f347b1f1.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a994614d071dc10f347b1f1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-03T10:04:02.926Z", "updatedon": "2026-09-03T10:04:02.926Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//telmisartan-and-metoprolol-succinate-25mg/483", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Telmaheal Beta", "category": "cardiac", "tags": [ "Telmaheal Beta Tablets", "Telmisartan Metoprolol Succinate", "Telmisartan Metoprolol Tablets", "Metoprolol Succinate 25mg Combination" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a99433e905b25d2f99f871c", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Telmisartan and Chlorthalidone 12.5mg Tablet", "description": "Why This Combination Is Important\n\nTelmaheal CT may be prescribed when one medicine alone does not provide enough blood-pressure control.\n\nRegular control of high blood pressure is important because untreated hypertension can increase the long-term risk of problems affecting the heart, brain, kidneys, and blood vessels.\n\n\nPossible Side Effects\n\nSome people may experience:\n\nDizziness\nHeadache\nWeakness or tiredness\nLow blood pressure\nIncreased urination\nChanges in sodium or potassium levels\nIncreased uric acid\nChanges in kidney function\n\nSevere dizziness, fainting, very low blood pressure, unusual weakness, irregular heartbeat, or serious allergic symptoms need medical attention.\n\nPrecautions\n\nExtra care may be needed in people with:\n\nKidney problems\nLiver problems\nLow blood pressure\nDehydration\nElectrolyte imbalance\nGout or high uric acid\nDiabetes\nPrevious allergic reactions to either ingredient\n\nBlood pressure, kidney function, sodium and potassium levels may need to be checked during treatment.\n\nPregnancy Safety\n\nMedicines containing Telmisartan should not be used during pregnancy, particularly because drugs acting on the renin-angiotensin system can seriously harm the developing fetus.\n\nPatients who become pregnant while taking this medicine should contact their healthcare professional promptly.\n\nDehydration & Electrolyte Safety\n\nBecause Chlorthalidone increases salt and water removal, excessive fluid loss can sometimes cause:\n\nDizziness • Low blood pressure • Dehydration • Sodium changes • Potassium changes\n\nThis risk can be greater during vomiting, diarrhea, heavy sweating, or inadequate fluid intake.\n\nMedicine Interaction Check\n\nThe healthcare professional should know about other medicines being taken, particularly:\n\nOther blood-pressure medicines\nPotassium supplements\nPotassium-containing salt substitutes\nCertain diuretics\nNSAID painkillers\nLithium\nMedicines that can affect kidney function or electrolytes\nStorage & Handling\nKeep tablets in the original packaging.\nStore according to the temperature stated on the product pack.\nProtect from excessive heat and moisture.\nKeep the blister dry and undamaged.\nDo not use after the expiry date.\nKeep out of reach of children.\nDo not use tablets if the packaging is damaged or product quality appears affected.\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 482, "imageuri": "https://productimages.withfloats.com/actual/6a9943406f22c7443093f743.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a9943406f22c7443093f743.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-03T09:51:58.344Z", "updatedon": "2026-09-03T09:51:58.344Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//telmisartan-and-chlorthalidone-12-5mg-tablet/482", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Telmaheal CT", "category": "cardiac", "tags": [ "Telmaheal Ct 12.5 Tablet 15: Uses, Side Effects, Price", "Telmisartan Chlorthalidone Tablets", "Chlorthalidone 12.5mg Combination" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a9925cc017883aea120fe9c", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rosuvastatin and Aspirin Capsule", "description": "Rosufree-A 10/75 & Rosufree-A 20/75 Tablets\nRosuvastatin + Aspirin\n\nRosufree-A is a fixed-dose cardiovascular combination containing Rosuvastatin and Aspirin. It combines lipid-lowering activity with antiplatelet action and may be prescribed for selected patients who require management of cholesterol alongside prevention of unwanted platelet aggregation.\n\nProduct Variants\n\nRosufree-A 10/75\nRosuvastatin 10 mg + Aspirin 75 mg\n\nRosufree-A 20/75\nRosuvastatin 20 mg + Aspirin 75 mg\n\nTherapeutic Segment: Cardiovascular\nMedicine Type: Statin + Antiplatelet Combination\nRoute: Oral\n\nOne Combination, Two Cardiovascular Objectives\nCholesterol Management\n\nRosuvastatin works primarily in the liver. By inhibiting HMG-CoA reductase, it decreases cholesterol synthesis and increases hepatic removal of circulating LDL cholesterol.\n\nThis can contribute to reductions in:\n\nLDL cholesterol\nTotal cholesterol\nNon-HDL cholesterol\nTriglycerides\n\nRosufree-A: Two Separate Safety Profiles\nROSUVASTATIN — Watch the Muscles\n\nUnexplained muscle pain, tenderness, cramps, or weakness can occur during statin treatment. Rarely, serious muscle injury such as rhabdomyolysis can develop.\n\nSignificant muscle symptoms, particularly when accompanied by dark urine or marked weakness, need prompt medical assessment.\n\nASPIRIN — Watch for Bleeding\n\nAspirin reduces platelet aggregation and can therefore increase bleeding tendency.\n\nWarning signs can include:\n\nUnusual bruising • Persistent bleeding • Blood in stools • Black/tarry stools • Vomiting blood • Blood in urine\n\nGastrointestinal irritation and ulcer-related bleeding are also important considerations.\n\n\nFrequently Asked Questions\n\n1. Why are Rosuvastatin and Aspirin combined?\nRosuvastatin manages abnormal lipid levels, while Aspirin reduces platelet aggregation. They therefore provide two distinct cardiovascular actions.\n\n2. How does Rosufree-A 10/75 differ from 20/75?\nBoth contain Aspirin 75 mg. The Rosuvastatin component changes from 10 mg to 20 mg.\n\n3. Is Rosufree-A only intended for high cholesterol?\nNo. Because it also contains Aspirin, the combination should be used when there is an appropriate indication for antiplatelet therapy as well as lipid management.\n\n4. Can Aspirin cause stomach problems?\nYes. Aspirin can cause gastric irritation and may increase the risk of gastrointestinal ulceration or bleeding.\n\n5. What muscle symptoms are important with Rosuvastatin?\nPersistent or unexplained muscle pain, tenderness, or weakness should be reported, particularly if severe or accompanied by dark urine.\n\n6. Should healthcare professionals know about Rosufree-A before surgery?\nYes. The Aspirin component affects platelet function, so doctors and dentists should know about treatment before invasive procedures.\n\n7. Can another blood thinner be taken with Rosufree-A?\nCombining Aspirin with anticoagulants or additional antiplatelet medicines can increase bleeding risk and requires medical assessment.\n\n8. Does Rosufree-A replace cholesterol-control lifestyle measures?\nNo. Medication is generally used alongside appropriate diet, physical activity, and management of other cardiovascular risk factors.\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 472, "imageuri": "https://productimages.withfloats.com/actual/6a9925ce7d3b71342af55fd3.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a9925ce7d3b71342af55fd3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-03T07:46:20.933Z", "updatedon": "2026-09-03T07:46:20.933Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//rosuvastatin-and-aspirin-capsule/472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rosufree-A", "category": "cardiac", "tags": [ "Rosufree-A 10/75", "Buy Rosufree-A 10/75 Capsule Online", "Rosufree-A 20/75", "Buy Rosufree-A 20/75 Capsule Online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a981d2fd57f56c9479e6b6d", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Telmisartan, Cilnidipine and Chlorthalidone Tablets", "description": "Telmaheal MCT 50/12.5, Telmaheal MCT 25/12.5 & Telmaheal Trio\n\nComposition: Telmisartan, Cilnidipine and Chlorthalidone\nDosage Form: Tablets\nTherapeutic Category: Antihypertensive Medicine\nProduct Type: Combination Cardiovascular Therapy\n\nTelmaheal MCT and Telmaheal Trio Tablets are combination antihypertensive medicines containing Telmisartan, Cilnidipine and Chlorthalidone. The combination brings together an angiotensin II receptor blocker, a calcium-channel blocker and a thiazide-like diuretic to support blood-pressure management through complementary mechanisms.\n\nThese medicines may be prescribed for patients who require multi-drug therapy for hypertension, particularly when adequate blood-pressure control is not achieved with simpler treatment regimens. Selection of the appropriate variant should be based on the patient's clinical condition and prescribed strength.\n\nAvailable Variants\nProduct\tActive Ingredients\nTelmaheal MCT 25/12.5\tTelmisartan + Cilnidipine + Chlorthalidone*\nTelmaheal MCT 50/12.5\tTelmisartan + Cilnidipine + Chlorthalidone*\nTelmaheal Trio\tTelmisartan + Cilnidipine + Chlorthalidone*\n\n*The exact individual strength of each component should be entered according to the product label.\n\nHow the Combination Supports BP Control\n\nTelmisartan blocks angiotensin II at AT1 receptors, helping reduce vasoconstriction and supporting relaxation of blood vessels.\n\nCilnidipine blocks calcium channels and reduces calcium entry into vascular smooth muscle, contributing to arterial relaxation and lower vascular resistance.\n\nChlorthalidone promotes sodium and water excretion through the kidneys, helping manage the volume-related component of elevated blood pressure.\n\nTogether, these actions provide a multi-pathway approach to hypertension management.\n\nKey Product Benefits\nCombines three antihypertensive mechanisms\nSupports effective management of elevated blood pressure\nProvides ARB, calcium-channel blocker and diuretic activity\nMay be suitable when combination therapy is clinically required\nConvenient fixed-dose treatment approach\nDesigned for prescription-based cardiovascular management\nWho May Be Prescribed This Combination?\n\nA Telmisartan + Cilnidipine + Chlorthalidone combination may be considered for selected adults with hypertension requiring multiple antihypertensive agents.\n\nIt is not appropriate to select the combination solely on the basis of a high BP reading. Kidney function, electrolyte status, other medicines and associated cardiovascular conditions should also be considered by the prescribing clinician.\n\nImportant Parameters During Treatment\n\nPatients receiving this combination may require periodic assessment of:\n\nBlood pressure\nKidney function\nSerum potassium\nSerum sodium\nHydration status\nUric acid when clinically relevant\nPossible Side Effects\n\nPossible treatment-related effects can include dizziness, headache, ankle swelling, increased urination, tiredness, low blood pressure, or electrolyte disturbances.\n\nChlorthalidone may contribute to low sodium or potassium and can increase uric acid, while Telmisartan may increase potassium in susceptible patients.\n\nPrecautions\n\nAdditional medical assessment may be necessary in patients with kidney impairment, liver problems, electrolyte abnormalities, gout, dehydration, low blood pressure, or diabetes.\n\nBecause Telmisartan acts on the renin-angiotensin system, Telmisartan-containing medicines should not be used during pregnancy due to the risk of fetal harm.", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 463, "imageuri": "https://productimages.withfloats.com/actual/6a981d31bd5eb1db62975c5a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a981d31bd5eb1db62975c5a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-02T12:57:19.347Z", "updatedon": "2026-09-02T12:57:19.347Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//telmisartan-cilnidipine-and-chlorthalidone-tablets/463", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Telmaheal", "category": "cardiac", "tags": [ "Telmaheal MCT 50/12.5", "Telmaheal MCT 25/12.5", "Telmaheal Trio Tablets", "Telmisartan Cilnidipine Chlorthalidone Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a97f3fff84e6e04481fbd96", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Candesartan Cilexetil 16 mg Tablet", "description": "Cardisartan 16 Tablets\n\nActive Ingredient: Candesartan Cilexetil 16 mg\nDosage Form: Oral Tablets\nMedicine Family: Angiotensin II Receptor Blocker (ARB)\nTherapeutic Segment: Cardiovascular\n\nMedicine Purpose\n\nCardisartan 16 contains Candesartan Cilexetil, an ARB medicine used primarily for blood-pressure management. Candesartan also has an established role in selected patients with heart failure, depending on approved labeling and individual clinical requirements.\n\nFrom Prodrug to Active Medicine\n\nCandesartan Cilexetil is a prodrug. After oral administration, it is converted in the body to active candesartan.\n\nThe active medicine selectively blocks angiotensin II AT1 receptors.\n\nLess vasoconstriction → Reduced vascular resistance → Lower blood pressure\n\nIt also reduces aldosterone-related effects of angiotensin II.\n\nCardisartan's Cardiovascular Roles\nHypertension\n\nHelps control elevated blood pressure and forms part of long-term cardiovascular risk management.\n\nHeart Failure\n\nCandesartan may be incorporated into treatment for certain patients with heart failure when clinically indicated.\n\nVascular Protection Strategy\n\nEffective blood-pressure management helps reduce the long-term burden that uncontrolled hypertension places on the heart, brain, kidneys, and blood vessels.\n\nPatient Checkpoints\n\nParticular care may be required when there is:\n\nKidney impairment\nSignificant dehydration or volume depletion\nElevated potassium\nLow blood pressure\nRenal artery stenosis\nConcurrent use of potassium supplements or other medicines affecting the renin-angiotensin system\nPossible Treatment Effects\n\nMost patients do not experience every adverse effect. Reported effects can include:\n\nDizziness | Hypotension | Headache | Increased potassium | Changes in kidney function\n\nSignificant facial, lip, tongue, or throat swelling requires urgent medical attention.\n\nPregnancy: Major Restriction\n\nMedicines acting on the renin-angiotensin system, including Candesartan, can cause serious fetal harm. Cardisartan should not be used during pregnancy, and pregnancy occurring during treatment requires prompt medical consultation.\n\n\nFAQs\n\n1. What does “Cilexetil” mean in Candesartan Cilexetil?\nIt refers to the prodrug form that is converted to active candesartan after administration.\n\n2. Does Cardisartan 16 slow the heartbeat?\nIt does not primarily work by slowing heart rate. Its main action is blocking angiotensin II receptors and reducing vascular resistance.\n\n3. Why might potassium be checked?\nARB medicines can increase serum potassium, particularly in patients with kidney problems or those using other potassium-increasing medicines.\n\n4. Is Cardisartan only used for hypertension?\nNo. Candesartan may also have a therapeutic role in certain patients with heart failure, according to approved indications.\n\n5. Should treatment be stopped once blood pressure becomes normal?\nA normal reading may reflect effective treatment. Antihypertensive therapy should not be changed or discontinued without medical guidance.\n\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 445, "imageuri": "https://productimages.withfloats.com/actual/6a97f401ce51fa6918ca24cc.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a97f401ce51fa6918ca24cc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-02T10:01:35.115Z", "updatedon": "2026-09-02T10:01:35.115Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//candesartan-cilexetil-16-mg-tablet/445", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cardisartan", "category": "cardiac", "tags": [ "Candesartan: View Uses, Side Effects and Medicines", "Candesartan (oral route) - Side effects & dosage", "Candesartan 16 mg tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a97d5348c60f7d4b5efeb24", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Warfarin Sodium Tablets 1,2 and 5mg", "description": "Warfox 1 | Warfox 2 | Warfox 5\n\nActive Ingredient: Warfarin Sodium\nStrengths: 1 mg, 2 mg & 5 mg\nDosage Form: Oral Tablets\nDrug Group: Vitamin K Antagonist (VKA)\nTherapeutic Category: Oral Anticoagulant\n\nWhat Makes Warfox Different?\n\nWarfox contains Warfarin Sodium, an anticoagulant medicine that reduces the formation of harmful blood clots. Unlike medicines that dissolve an existing clot directly, Warfarin primarily works by reducing the body's ability to produce certain functional clotting factors.\n\n\nStrength Selector\n\nTablet\tWarfarin Sodium\nWarfox 1\t1 mg\nWarfox 2\t2 mg\nWarfox 5\t5 mg\n\nSituations Where Anticoagulation May Be Required\n\nDepending on the individual patient's condition and approved labeling, Warfarin may be prescribed for the treatment or prevention of thromboembolic complications, including selected patients with:\n\nDeep Vein Thrombosis (DVT) — clot formation in a deep vein\nPulmonary Embolism (PE) — clot migration to pulmonary circulation\nAtrial Fibrillation — reduction of embolic stroke risk in appropriate patients\nMechanical Heart Valves — anticoagulation in selected valve patients\nRecurrent Thromboembolism — prevention when continued anticoagulation is indicated\n\nBleeding Is the Main Safety Concern\n\nBecause Warfarin interferes with coagulation, bleeding is its most important adverse effect.\n\nMedical assessment is particularly important for:\n\nUnexplained or prolonged bleeding\nBlood in urine\nBlack or bloody stools\nVomiting or coughing blood\nUnusually heavy menstrual bleeding\nFrequent unexplained bruising\nSevere or unusual headache\nSignificant falls or head injuries\n\nPregnancy Warning\n\nWarfarin can cause serious fetal harm and is generally contraindicated during pregnancy, although management of certain exceptional clinical situations requires specialist assessment.\n\nAnyone taking Warfarin who is pregnant, suspects pregnancy, or plans pregnancy should promptly discuss anticoagulation management with the treating specialist.\n\nFAQs\n\n1. Why does Warfox come in three strengths?\nWarfarin dosing often requires precise adjustment based on INR response and clinical factors. Different tablet strengths help clinicians individualize treatment.\n\n2. Is Warfox a blood thinner?\nIt is commonly described as a blood thinner, although technically it is an anticoagulant that reduces the formation of functional vitamin-K-dependent clotting factors.\n\n3. Can the Warfox dose stay the same permanently?\nNot necessarily. Illness, diet, interacting medicines, and other factors can alter Warfarin response, so INR-guided adjustment may occasionally be necessary.\n\n4. Why are INR tests repeated?\nWarfarin has a relatively narrow therapeutic range and considerable variability between individuals. INR monitoring helps balance clot prevention against bleeding risk.\n\n5. Should green vegetables be completely avoided?\nUsually the important principle is consistency rather than complete avoidance of vitamin-K-containing foods, unless a healthcare professional gives different dietary instructions.\n\n6. Can painkillers be taken with Warfox?\nSome pain medicines, particularly certain NSAIDs, can increase bleeding risk. Patients should check with a healthcare professional before adding over-the-counter medicines.\n\n7. What if a Warfox dose is forgotten?\nPatients should follow their prescribed anticoagulation instructions and should not automatically double the next dose to compensate for a missed tablet.\n\n8. Why is Warfarin considered a high-monitoring medicine?\nIts effect can be influenced by diet, illnesses, genetics, and numerous medicines, while excessive anticoagulation can result in serious bleeding. Regular clinical and INR monitoring is therefore important.\n\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 433, "imageuri": "https://productimages.withfloats.com/actual/6a97d536ae543c1ca6823a29.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a97d536ae543c1ca6823a29.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-02T07:50:12.755Z", "updatedon": "2026-09-02T07:50:12.755Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//warfarin-sodium-tablets-1-2-and-5mg/433", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Warfox", "category": "General Medicine", "tags": [ "Warfox 5 Tablet – Warfarin 5mg | DVT & Stroke Prevention", "Warfox 2 Tablet – Warfarin 2mg | Blood Clot Prevention", "Buy Warfox 1mg Tablet 10s Online", "Warfarin Sodium Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a97c9a76f0d40d75ec68f3c", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sodium Valproate and Valproic Acid Tablets", "description": "Valpodium 200 & Valpodium 500 Tablets\n\nActive Ingredients: Sodium Valproate + Valproic Acid\nTablet Strengths: 200 mg and 500 mg*\nMedicine Family: Antiepileptic / Anticonvulsant\nTherapeutic Field: Neurology\n\nThe exact contribution of Sodium Valproate and Valproic Acid to the stated 200 mg and 500 mg strengths should be confirmed from the product label.\n\nValpodium in One View\n\nValpodium is a valproate-based medicine designed to help control abnormal electrical activity in the brain. Valproate medicines have broad anticonvulsant activity and may be prescribed for different types of epilepsy and seizure disorders, depending on the patient's diagnosis and approved labeling.\n\nValpodium 200 provides a lower-strength presentation, while Valpodium 500 provides a higher-strength option for individualized physician-directed therapy.\n\nWhere Valproate Fits in Neurological Care\n\nValproate has activity across several seizure types rather than being limited to a single seizure pattern.\n\nA specialist may consider valproate therapy for certain:\n\nGeneralized seizures\nIncluding appropriate generalized epilepsy syndromes.\n\nFocal seizures\nMay be considered in selected patients depending on seizure classification.\n\nMixed seizure patterns\nIts broad-spectrum anticonvulsant activity can be useful where more than one seizure type is present.\n\nOther indications for valproate exist in some markets, but the specific approved indication of Valpodium should be followed.\n\nBrain Activity: What Valproate Changes\n\nValproate works through several mechanisms rather than one isolated receptor.\n\nOne important action is enhancement of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid). It also influences voltage-dependent ion channels involved in neuronal firing.\n\nThe overall result is:\n\nLess excessive neuronal firing → Greater electrical stability → Reduced tendency toward seizures\n\nThe Valpodium Safety Triangle\n\nThree areas deserve particular attention during valproate treatment:\n\n01 | Liver\n\nValproate can rarely cause serious hepatotoxicity, particularly during the early period of treatment and in higher-risk patients.\n\n02 | Pancreas\n\nAcute pancreatitis is an uncommon but potentially severe complication. Persistent severe abdominal pain, particularly with vomiting, requires urgent assessment.\n\n03 | Pregnancy\n\nValproate has a major teratogenic and neurodevelopmental risk when taken during pregnancy. Its use in people who can become pregnant is subject to strict precautions and restrictions in many countries.\n\nSignals Worth Reporting\n\nSome adverse effects are relatively common and may include:\n\nNausea or gastrointestinal discomfort\nTremor\nDrowsiness\nDizziness\nWeight gain\nHair changes or temporary hair loss\n\nMore significant problems can include:\n\nAbnormal liver function\nReduced platelet count or bleeding tendency\nHyperammonemia\nPancreatitis\nSerious skin or hypersensitivity reactions\n\nPregnancy Risk Deserves Special Emphasis\n\nValproate exposure during pregnancy is associated with a substantial risk of major congenital malformations and developmental disorders.\n\nFor this reason, prescribing valproate to women and girls who could become pregnant is highly restricted in many jurisdictions. Applicable pregnancy-prevention requirements and local prescribing regulations must be followed.\n\nPatients should not independently stop valproate after discovering a pregnancy, because uncontrolled seizures can also be dangerous. Urgent specialist medical advice is required.\n\nMedicine-Combination Check\n\nValproate can interact with several medicines, including other antiepileptic drugs. Particularly important interactions may occur with medicines such as lamotrigine, because valproate can increase lamotrigine exposure and potentially increase adverse-effect risk.\n\n\nThings Patients Commonly Want to Know\n\n1. Is Valpodium a painkiller?\nNo. It is a valproate-based anticonvulsant medicine, not a conventional analgesic.\n\n2. Why are there 200 mg and 500 mg tablets?\nDifferent strengths provide flexibility for physician-directed therapy. The appropriate amount depends on the indication, formulation, clinical response, and individual patient factors.\n\n3. Can Valpodium make someone sleepy?\nYes. Drowsiness and dizziness can occur, especially during treatment initiation or adjustment.\n\n4. Why might blood tests be requested?\nValproate can affect the liver, platelets, and other laboratory parameters, making appropriate monitoring important.\n\n5. Should Valpodium be stopped when seizures disappear?\nNo treatment change should be made independently. Abrupt discontinuation can lead to seizure recurrence or worsening, so withdrawal should be medically supervised.\n\n6. Is Valpodium safe during pregnancy?\nValproate carries significant fetal and developmental risks. Its use during pregnancy and in people who can become pregnant requires strict specialist assessment and applicable pregnancy-prevention measures.\n\n7. What symptoms could indicate a serious liver problem?\nPersistent vomiting, unusual tiredness, abdominal symptoms, jaundice, or marked deterioration should receive prompt medical evaluation.\n\n8. What makes severe abdominal pain important?\nRarely, valproate can cause pancreatitis. Severe or persistent abdominal pain, especially with nausea or vomiting, requires urgent medical attention.\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 428, "imageuri": "https://productimages.withfloats.com/actual/6a97c9aabd5eb1db629754ec.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a97c9aabd5eb1db629754ec.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-02T07:00:55.504Z", "updatedon": "2026-09-02T07:00:55.504Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//sodium-valproate-and-valproic-acid-tablets/428", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Valpodium", "category": "General Medicine", "tags": [ "Valpodium 500 Cr Tablet 10 - Truemeds", "Sodium Valproate Tablets Valpodium 200CR", "Valpodium 200 CR - 200mg Tablet | Controlled Release", "Valpodium 500 CR" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a96642f007af3fb3a9dfb58", "fptag": "ERNESTPHARMACEUTICAL", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rosuvastatin, Aspirin and Clopidogrel Capsules", "description": "Rosufox Gold 10 Capsules & Rosufox Gold 20 Capsules\n\nActive Ingredients: Rosuvastatin + Aspirin + Clopidogrel\nDosage Form: Capsules\nTherapeutic Category: Cardiovascular / Lipid-Lowering + Dual Antiplatelet Therapy\n\nProduct Overview\n\nRosufox Gold Capsules are combination cardiovascular medicines containing Rosuvastatin, Aspirin, and Clopidogrel. The formulation combines cholesterol management with antiplatelet activity and may be prescribed to selected patients who require these therapies together for cardiovascular risk management or prevention of recurrent atherothrombotic events, depending on approved labeling.\n\nThree-Way Therapeutic Action\nRosuvastatin\n\nA statin that reduces LDL cholesterol by inhibiting HMG-CoA reductase and increasing hepatic clearance of LDL.\n\nAspirin\n\nProvides antiplatelet activity through irreversible inhibition of platelet COX-1 and reduced thromboxane A2 formation.\n\nClopidogrel\n\nAn antiplatelet medicine that inhibits the platelet P2Y12 ADP receptor, reducing platelet activation and aggregation.\n\nRosufox Gold Range\nProduct\tCombination\nRosufox Gold 10 Capsules\tRosuvastatin 10 mg+ Aspirin + Clopidogrel\nRosufox Gold 20 Capsules\tRosuvastatin 20 mg + Aspirin + Clopidogrel\n\nVerify all individual component strengths against the label.\n\nWhy This Combination Requires Careful Selection\n\nBecause Rosufox Gold contains two antiplatelet medicines, bleeding risk is an important consideration. Before treatment, healthcare professionals should review:\n\nPrevious gastrointestinal or other significant bleeding\nActive peptic ulcer disease\nLiver or kidney impairment\nPlanned surgery or dental procedures\nConcurrent anticoagulants, NSAIDs, or other medicines that increase bleeding risk\nPrevious statin-related muscle problems\nDrug interactions\nPossible Adverse Effects\n\nPotential effects include:\n\nEasy bruising\nNosebleeds or prolonged bleeding\nIndigestion or stomach discomfort\nHeadache\nMuscle aches\nNausea\n\nMore serious concerns include major bleeding, gastrointestinal bleeding, severe allergic reactions, liver abnormalities, and statin-associated muscle injury.\n\n\nFAQs\n\n1. What does Rosufox Gold contain?\nIt contains Rosuvastatin, Aspirin, and Clopidogrel in a fixed-dose combination.\n\n2. What is the difference between Rosufox Gold 10 and Gold 20?\nBased on the product names provided, they appear to differ in the Rosuvastatin strength (10 mg versus 20 mg). The complete composition should be confirmed from each pack.\n\n3. Why are Aspirin and Clopidogrel included?\nBoth reduce platelet aggregation through different mechanisms and are used as antiplatelet medicines in appropriately selected cardiovascular patients.\n\n4. Does Rosufox Gold lower cholesterol?\nYes. The Rosuvastatin component lowers LDL cholesterol and other atherogenic lipids.\n\n5. Can Rosufox Gold increase bleeding?\nYes. Aspirin and Clopidogrel both affect platelet function, so bleeding is an important risk.\n\n6. Can Rosufox Gold cause muscle pain?\nRosuvastatin can cause muscle symptoms. Severe or unexplained muscle pain or weakness should be medically evaluated.\n\n7. Should Rosufox Gold be stopped before surgery?\nAny decision to interrupt antiplatelet therapy must be made by the treating healthcare professional, balancing bleeding and thrombosis risks.\n\n8. Is Rosufox Gold a prescription medicine?\nYes. This combination requires medical supervision, particularly because of its dual antiplatelet components.\n\n", "price": 0.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 386, "imageuri": "https://productimages.withfloats.com/actual/6a966431494e1513805b9250.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a966431494e1513805b9250.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-09-01T05:35:43.59Z", "updatedon": "2026-09-01T05:35:43.59Z", "buyonlinelink": null, "producturl": "https://WWW.ERNESTIMPEX.IN//rosuvastatin-aspirin-and-clopidogrel-capsules/386", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rosufox Gold", "category": "General Medicine", "tags": [ "Rosufox Gold 10 Capsules", "Rosufox Gold 20 Capsules", "Rosuvastatin Aspirin Clopidogrel Combination", "Rosufox Gold Capsules" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "None", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }